Investing Profile

Lori Hu

InvestorVC
Managing Director at Vertex Ventures HC
ertexventureshc.comSan Francisco Bay Area
Photo of Lori Hu, Managing Director at Vertex Ventures HC

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Accenture Network
268 CONNECTIONS
Duke University Network
195 CONNECTIONS
University of Pennsylvania - The Lauder Institute Network
18 CONNECTIONS
Bristol Myers Squibb Network
15 CONNECTIONS
cb
Vertex Ventures HC Managing Director
$100K - $200K
$150K
6
$400M
CompanyStageDateRound SizeTotal Raised
SonoThera
Series BJun 2026$130M
Series ADec 2022$61M
$190M
Co-investors: Rajul Jain (Vida Ventures, LLC), Brian Halak (Medical Excellence Capital, LLC), Asish Xavier (Johnson & Johnson Innovation), Steven Gillis (ARCH Venture Partners), Tom Willis (Illuminate Ventures), Lu Wang (Foothill Ventures (formerly Tsingyuan Ventures))
NeuSpera Medical
Series DJul 2024$23M
Series CJul 2021$65M
$130M
Co-investors: Ching Zhu (Creacion Ventures)
Indapta Therapeutics
Series AFeb 2022$50M
$50M
Co-investors: Laura Stoppel (RA Capital Management)
BlackThorn Therapeutics
Series BJun 2019$76M
$130M
Co-investors: Brian Chee (Polaris Partners), Paul Berns (ARCH Venture Partners), Julie Sunderland (Biomatics Capital Partners)
Management Consultant AccenturePresent
Associate Director, Business Development Bristol Myers SquibbPresent
VC Associate SR One Capital ManagementPresent
Board Observer MoximedPresent
Board Observer Ivantis, IncPresent
Managing Director Vertex Ventures USPresent
Managing Director Vertex Ventures HCPresent
Board Director Palleon PharmaceuticalsPresent
Board Director BlackThorn TherapeuticsPresent
Board Director Elevation OncologyPresent
Board Director Neuspera Medical Inc.Present
Board Director Indapta TherapeuticsPresent
Board Director SonoTheraPresent
Board Observer TORL BioTherapeutics LLCPresent
Duke University Bachelor of Science Biomedical Engineering
University of Pennsylvania - The Lauder Institute Master's Degree International Studies